An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT� (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients (CHAMPS II)
Clinical trial NCT00317902 · COMPLETED
Trial details
- NCT number
- NCT00317902
- Sponsor
- Ortho Biotech Products, L.P.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2002-10-01
- Enrollment
- 292
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.